Siemens Healthineers AG Cash Flow Conversion Efficiency
Siemens Healthineers AG cash flow conversion efficiency. Based on the latest financial reports, Siemens Healthineers AG (SHL) has a cash flow conversion efficiency ratio of 0.064x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€1.23 Billion ≈ $1.44 Billion USD) by net assets (€19.16 Billion ≈ $22.40 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Siemens Healthineers AG (2017–2024)
Cash flow conversion efficiency of Siemens Healthineers AG from 2017 to 2024. This chart illustrates how Siemens Healthineers AG's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Siemens Healthineers AG stock price for real-time trading data and today's change.
Siemens Healthineers AG Cash Flow Conversion Ratio Explained
Siemens Healthineers AG cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Siemens Healthineers AG Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Siemens Healthineers AG ranked by their cash flow conversion efficiency. Also see Siemens Healthineers AG (SHL) total market value for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
STANDARD CHART.UNSP.ADR/2
F:STD0
|
N/A |
|
Skandinaviska Enskilda Banken AB (publ)
ST:SEB-A
|
0.151x |
|
Comfort Systems USA Inc
NYSE:FIX
|
0.354x |
|
CITIC Securities Co Ltd
SHG:600030
|
0.221x |
|
Cardinal Health Inc
NYSE:CAH
|
-0.682x |
|
Teradyne Inc
NASDAQ:TER
|
0.101x |
|
ST GOBAIN ADR 1/5/EO 4
F:GOBU
|
N/A |
|
HEINEKEN SP. ADR 1/2
F:HNK2
|
N/A |
Annual Cash Flow Conversion Efficiency for Siemens Healthineers AG (2017–2024)
The table below shows the annual cash flow conversion efficiency of Siemens Healthineers AG from 2017 to 2024. Review Siemens Healthineers AG free cash flow ratio to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-09-30 | €18.25 Billion ≈ $21.33 Billion |
€2.83 Billion ≈ $3.30 Billion |
0.155x | +32.52% |
| 2023-09-30 | €18.13 Billion ≈ $21.20 Billion |
€2.12 Billion ≈ $2.48 Billion |
0.117x | -7.35% |
| 2022-09-30 | €19.85 Billion ≈ $23.21 Billion |
€2.50 Billion ≈ $2.93 Billion |
0.126x | -29.73% |
| 2021-09-30 | €16.34 Billion ≈ $19.10 Billion |
€2.93 Billion ≈ $3.43 Billion |
0.180x | +16.49% |
| 2020-09-30 | €12.51 Billion ≈ $14.63 Billion |
€1.93 Billion ≈ $2.25 Billion |
0.154x | -6.77% |
| 2019-09-30 | €9.78 Billion ≈ $11.44 Billion |
€1.62 Billion ≈ $1.89 Billion |
0.165x | -10.08% |
| 2018-09-30 | €8.68 Billion ≈ $10.14 Billion |
€1.59 Billion ≈ $1.86 Billion |
0.184x | -69.82% |
| 2017-09-30 | €3.24 Billion ≈ $3.79 Billion |
€1.98 Billion ≈ $2.31 Billion |
0.609x | -- |
About Siemens Healthineers AG
Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers in Germany, the United States, rest of Europe, CIS, Africa, the Middle East, the Americas, the Asia Pacific, Japan, and China. It operates in four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment… Read more